Liraglutide (Saxenda for obesity, Victoza for diabetes) is administered as a once-daily subcutaneous injection
Emerging evidencestrengthened by ASCO GI 2026suggests that GLP-1 receptor agonists may define the next era by addressing the metabolic roots of colorectal carcinogenesis
During caloric restriction, with or without GLP-1 aids, the weight lost by patients is a mix of lean mass and fat mass
Clinical trials for Wegovy, a weight loss drug with the same active ingredient, semaglutide, found that insomnia rates were roughly the same in semaglutide groups versus placebo groups
Wound healing has become more than a theoretical concern for GLP-1 patients, with surgeons increasingly reporting post-op complications, because of nutritional deficiencies in Ozempic patients and the way these can compromise wound healing and collagen in the skin
OTC benefit card: If you ...Pickup availableSame Day Delivery availableShipping Available Pickup availableSame Day Delivery availableShipping Available Diabetes Doctor Dr
